The funding round would value the company at around €20 billion (about $23.15 billion), nearly double its Series C valuation of €11.7 billion.
Mistral is rumored to be raising €3B at €20B valuation
Related Posts
Insilico Medicine advances AI drug for IPF to Phase III trials
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic…
Deploying retail AI to scale personalisation and customer insight
Optimising retail AI infrastructure drives the successful deployment of personalisation systems and real-time customer insight. Leaders are replacing…
The AI legal services industry is heating up — Anthropic is getting in on the action
Anthropic’s new tools are designed to help law firms automate specific clerical functions — things like document search…
